Sign up now to have the right to view
50 tenders for free.
| Title |
Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Cladribine (Obo), Atc L04aa40 for the Period December 1St, 2024 - November 30Th, 2026 Tender Notice International Competitive Bidding |
|||
|---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
| Country | ||||
| Language | English | |||
| Organization | ||||
| Published Date | 16.10.2024 | |||
| Deadline Date | 05.10.2026 | |||
| Overview |
Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Cladribine (Obo), Atc L04aa40 for the Period December 1St, 2024 - November 30Th, 2026 Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts DAK HEALTH Address : Nagelsweg 27-31 Town : Hamburg NUTS-Code : DE - Deutschland Postal Code : 20097 Phone : +49 4023648553000 Fax : +49 4033470-900200 vergabestelleam@dak.de Tender Notice International Competitive Bidding 626630-2024 Germany GT-108723210
|
|||
| NAICS | ||||
| CPVS | ||||
| UNSPSC | ||||
| Regions | ||||
| Sectors | ||||
| URL | ||||
| Share | ||||
Germany
| Title |
|---|
Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Cladribine (Obo), Atc L04aa40 for the Period December 1St, 2024 - November 30Th, 2026 Tender Notice International Competitive Bidding |
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 16.10.2024 |
| Deadline Date |
| 05.10.2026 |
| Overview |
| Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Cladribine (Obo), Atc L04aa40 for the Period December 1St, 2024 - November 30Th, 2026 Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts DAK HEALTH Address : Nagelsweg 27-31 Town : Hamburg NUTS-Code : DE - Deutschland Postal Code : 20097 Phone : +49 4023648553000 Fax : +49 4033470-900200 vergabestelleam@dak.de Tender Notice International Competitive Bidding 626630-2024 Germany GT-108723210 |
| NAICS |
| Other Direct Insurance (except Life Justice Regulation Justice Other Justice Regulation Direct Insurance (except Life Direct Life International Other Justice |
| CPVS |
| Sections Postal orders |
| UNSPSC |
| Awards Cladribine IP phones |
| Regions |
| Europe Western Europe |
| Sectors |
| Healthcare and Medicine Banking-Finance-Insurance Postal and Courier Services Roads and Highways-Bridge Printing and Publishing Railways-Rail-Railroad Electricity Construction Consultancy Energy-Power and Electrical Computer Hardwares and Consumables Steel Pharmaceuticals |
| URL |
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Tenders